Bipolar Disorder Trial, Recruiting NCT07627178 Sponsor: Tanta University Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07627178
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male and have been diagnosed with an enlarged prostate (a condition called BPH)
  • People who have been diagnosed with BPH and are experiencing bothersome urinary symptoms
  • People whose urinary symptom score is 20 or higher on a standard questionnaire, meaning symptoms are classed as severe
  • People whose urine flow rate is very slow — specifically 10 mL per second or less when measured during a flow test
  • People whose prostate has been measured (by an internal ultrasound scan) and found to be larger than 100 mL in size
  • People whose symptoms have not improved with medication and who have been assessed as suitable for surgery

Who may not be able to join:

  • People who currently have, or have previously had, prostate cancer
  • People who have had previous surgery on the prostate
  • People who have had previous surgery on the urethra (the tube that carries urine out of the body)
  • People whose bladder does not function properly due to a nerve or neurological condition
  • People who currently have an active urinary tract infection
  • People with very severe heart or cardiovascular disease (confirm with trial site)
  • People who have previously had radiation therapy to the pelvic area
  • People who have a narrowing or blockage in the urethra
  • People who have bladder stones

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hassan Hussein El-Tatawy, MD, Tanta University Faculty of Medicine

Phone: +201221430915

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tanta University
Registry
ClinicalTrials.gov
Start date
21 October 2025
Est. completion
30 November 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

International Prostate Symptom Score (IPSS); Quality of Life Score (QoL); Maximum Urinary Flow Rate (Qmax); Post-Void Residual Urine Volume (PVR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov